Published in AJR Am J Roentgenol on April 01, 2007
Is breast cancer the same disease in Asian and Western countries? World J Surg (2010) 2.33
Breast cancer in Chinese women younger than age 40: are they different from their older counterparts? World J Surg (2008) 1.03
Distribution of mammographic density and its influential factors among Chinese women. Int J Epidemiol (2014) 0.97
Mammographic density and breast cancer risk in White and African American Women. Breast Cancer Res Treat (2012) 0.96
Mammographic breast density patterns among a group of women in sub Saharan Africa. Afr Health Sci (2012) 0.93
Individually tailored screening of breast cancer with genes, tumour phenotypes, clinical attributes, and conventional risk factors. Br J Cancer (2013) 0.90
Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study. Ann Intern Med (2016) 0.90
Age and ethnic differences in volumetric breast density in new zealand women: a cross-sectional study. PLoS One (2013) 0.85
International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries. Cancer Epidemiol (2015) 0.85
Black breast cancer survivors experience greater upper extremity disability. Breast Cancer Res Treat (2015) 0.84
Distribution of dense breasts using screening mammography in Korean women: a retrospective observational study. Epidemiol Health (2014) 0.83
Breast US computer-aided diagnosis system: robustness across urban populations in South Korea and the United States. Radiology (2009) 0.82
A new full-field digital mammography system with and without the use of an advanced post-processing algorithm: comparison of image quality and diagnostic performance. Korean J Radiol (2014) 0.81
Efficacy of an educational material on second primary cancer screening practice for cancer survivors: a randomized controlled trial. PLoS One (2012) 0.80
Mammographic Breast Density Evaluation in Korean Women Using Fully Automated Volumetric Assessment. J Korean Med Sci (2016) 0.79
Comparison of new and established full-field digital mammography systems in diagnostic performance. Korean J Radiol (2013) 0.79
Mammography screening in less developed countries. Springerplus (2015) 0.78
Type 2 diabetes and mammographic breast density among underserved women. Cancer Causes Control (2014) 0.77
Positron emission mammography (PEM): reviewing standardized semiquantitative method. Ann Nucl Med (2013) 0.75
Survival outcomes of different treatment methods for the ipsilateral breast of occult breast cancer patients with axillary lymph node metastasis: a single center experience. J Breast Cancer (2013) 0.75
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Breast Cancer Res (2016) 0.75
The association of alcohol consumption with mammographic density in a multiethnic urban population. BMC Cancer (2015) 0.75
Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology (2003) 5.42
Characterization of human atherosclerosis by optical coherence tomography. Circulation (2002) 5.04
Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation (2003) 4.69
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol (2002) 4.38
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA (2004) 4.36
A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Cancer (2013) 4.21
A rational approach to the stool ova and parasite examination. Clin Infect Dis (2006) 4.06
Tomographic mammography using a limited number of low-dose cone-beam projection images. Med Phys (2003) 3.70
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation (2008) 3.63
A comparison of reconstruction algorithms for breast tomosynthesis. Med Phys (2004) 3.41
Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol (2006) 3.28
In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation (2005) 3.23
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol (2014) 3.07
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. J Clin Oncol (2010) 3.02
Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst (2008) 2.94
Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol (2006) 2.74
Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging (2012) 2.72
Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14. J Clin Oncol (2011) 2.58
Utilization of diagnostic medical imaging: comparison of radiologist referral versus same-specialty referral. Radiology (2007) 2.48
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst (2002) 2.45
Application of recently developed computer algorithm for automatic classification of unstructured radiology reports: validation study. Radiology (2004) 2.36
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer. J Clin Oncol (2014) 2.25
Mammography screening is saving thousands of lives, but will it survive medical malpractice? Radiology (2004) 2.24
Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol (2005) 2.20
Consensus conference on breast conservation. J Am Coll Surg (2006) 2.17
Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology (2012) 2.14
Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression. Eur Heart J (2006) 2.13
Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy. J Clin Oncol (2005) 2.09
Institutional academic industry relationships. JAMA (2007) 2.05
Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol (2005) 2.05
Noninvasive assessment of murine pulmonary arterial pressure: validation and application to models of pulmonary hypertension. Circ Cardiovasc Imaging (2009) 2.05
Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J Neurosci (2003) 2.05
Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol (2004) 2.03
Enhanced imaging of microcalcifications in digital breast tomosynthesis through improved image-reconstruction algorithms. Med Phys (2009) 2.02
Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J (2006) 1.98
CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology (2002) 1.98
Consensus interpretation in imaging research: is there a better way? Radiology (2010) 1.94
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. Lancet Oncol (2012) 1.94
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol (2011) 1.93
Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology (2005) 1.91
CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure. AJR Am J Roentgenol (2006) 1.89
Coregistered tomographic x-ray and optical breast imaging: initial results. J Biomed Opt (2005) 1.89
Persistent and reversible cardiac dysfunction among amateur marathon runners. Eur Heart J (2006) 1.88
Diffusion tensor MRI of myocardial fibers and sheets: correspondence with visible cut-face texture. J Magn Reson Imaging (2003) 1.88
CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology (2002) 1.85
Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine. Gastrointest Endosc (2009) 1.79
Combined optical and X-ray tomosynthesis breast imaging. Radiology (2010) 1.76
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med (2015) 1.76
Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression. IEEE Trans Med Imaging (2009) 1.76
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial. Lancet Oncol (2012) 1.75
Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy. Steroids (2007) 1.75
Automated computer-assisted categorization of radiology reports. AJR Am J Roentgenol (2005) 1.74
Tomographic optical breast imaging guided by three-dimensional mammography. Appl Opt (2003) 1.69
Attenuation of acute and chronic pulmonary emboli. Radiology (2005) 1.69
Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AJR Am J Roentgenol (2009) 1.68
The status of appendiceal CT in an urban medical center 5 years after its introduction: experience with 753 patients. AJR Am J Roentgenol (2005) 1.66
Mammographic screening: patterns of use and estimated impact on breast carcinoma survival. Cancer (2004) 1.66
Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer? J Thorac Oncol (2006) 1.64
Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol (2003) 1.63
Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction. J Clin Oncol (2009) 1.61
Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res (2005) 1.59
Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles. Prostate (2010) 1.52
Longer-term outcomes of letrozole versus placebo after 5 years of tamoxifen in the NCIC CTG MA.17 trial: analyses adjusting for treatment crossover. J Clin Oncol (2011) 1.51
Blinded comparison of computer-aided detection with human second reading in screening mammography. AJR Am J Roentgenol (2007) 1.51
Aromatase inhibitors and bone health in women with breast cancer. J Clin Oncol (2006) 1.51
Breast cancer in Brazil: present status and future goals. Lancet Oncol (2012) 1.49
Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT--10-minute delayed imaging protocol revisited in a large patient cohort. Radiology (2010) 1.49
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Breast J (2009) 1.48
Acute brain infarct: detection and delineation with CT angiographic source images versus nonenhanced CT scans. Radiology (2007) 1.48
Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening. Breast Cancer Res Treat (2012) 1.46
Advances in adjuvant hormonal therapy for postmenopausal women. J Clin Oncol (2005) 1.44
Prenatally diagnosed fetal conditions in the age of fetal care: does who counsels matter? Am J Obstet Gynecol (2012) 1.43
Lapatinib: current status and future directions in breast cancer. Oncologist (2006) 1.43
Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology (2007) 1.42
Case records of the Massachusetts General Hospital. Case 24-2005. A 58-year-old woman with early-stage estrogen-receptor-positive breast cancer. N Engl J Med (2005) 1.40
Mammography: yet another challenge. Radiology (2009) 1.39
Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17. J Clin Oncol (2008) 1.39
Not so fast: the use of incomplete data to devalue the role of mammography screening. Breast Cancer Res Treat (2012) 1.39
What's New in Genetic Testing for Cancer Susceptibility? Oncology (Williston Park) (2016) 1.38
Lifetime Costs of Prophylactic Mastectomies and Reconstruction versus Surveillance. Plast Reconstr Surg (2015) 1.37
Predicting the survival of patients with breast carcinoma using tumor size. Cancer (2002) 1.34
Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J Leukoc Biol (2009) 1.34
Hyperdense basilar artery sign on unenhanced CT predicts thrombus and outcome in acute posterior circulation stroke. Stroke (2008) 1.33
The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer. Oncologist (2008) 1.32
Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib. Clin Cancer Res (2011) 1.31